Cargando…
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
Increased glucose uptake and metabolism is a prominent phenotype of most cancers, but efforts to clinically target this metabolic alteration have been challenging. Here, we present evidence that lactoylglutathione (LGSH), a byproduct of methylglyoxal detoxification, is elevated in both human and mur...
Autores principales: | Luengo, Alba, Abbott, Keene L., Davidson, Shawn M., Hosios, Aaron M., Faubert, Brandon, Chan, Sze Ham, Freinkman, Elizaveta, Zacharias, Lauren G., Mathews, Thomas P., Clish, Clary B., DeBerardinis, Ralph J., Lewis, Caroline A., Vander Heiden, Matthew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898239/ https://www.ncbi.nlm.nih.gov/pubmed/31811141 http://dx.doi.org/10.1038/s41467-019-13419-4 |
Ejemplares similares
-
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma
por: Dayton, Talya L., et al.
Publicado: (2016) -
Acetate metabolism in cancer cells
por: Hosios, Aaron M, et al.
Publicado: (2014) -
The CAT-SIR is out of the bag: tumors prefer host rather than dietary nutrients
por: Abbott, Keene L., et al.
Publicado: (2021) -
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1-mutant lung cancer
por: Kim, Jiyeon, et al.
Publicado: (2020) -
Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
por: Luengo, Alba, et al.
Publicado: (2014)